A Chinese herbal medication called SS-1 can reduce inflammation and improve saliva flow, likely due to an inhibitory effect on…
Forest Ray PhD
Forest Ray received his PhD in systems biology from Columbia University, where he developed tools to match drug side effects to other diseases. He has since worked as a journalist and science writer, covering topics from rare diseases to the intersection between environmental science and social justice. He currently lives in Long Beach, California.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Forest Ray PhD
People with early-onset primary Sjögren’s syndrome may need more intensive glucocorticoid and immunosuppressant therapy, closer follow-up, and regular monitoring than…
The amount of a protein called ATG5 in tears may pinpoint people whose dry eye symptoms are related to…
Using the PI3K-delta inhibitor seletalisib as an add-on to standard treatment showed a trend toward easing disease activity and…
Attention deficits may underlie the cognitive impairment that impacts a substantial portion of Sjögren’s syndrome patients with neurological symptoms,…
The University of Queensland’s technology transfer company, UniQuest, will partner with the biotechnology company CSL Limited to…